Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2020

Aug 5, 2020

29841_dirs_2020-08-05_65ceb73e-f1e8-4ab7-a037-6b77be68d5e6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2020-08-03

Reporting Person: TEN HOEDT ROB (EVP & President EMEA)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-08-03 Ordinary Shares A 5754 Acquired 62623 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-08-03 Stock Option (Right to Buy) $97.33 A 52896 Acquired 2030-08-03 Ordinary Shares (52896) Direct
2020-08-03 Stock Option (Right to Buy) $97.33 A 1575 Acquired 2030-08-03 Ordinary Shares (1575) Direct
2020-08-03 Stock Option (Right to Buy) $97.33 A 42191 Acquired 2030-08-03 Ordinary Shares (42191) Direct

Footnotes

F1: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date.

F2: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.